Health
Pfizer to submit emergence use approval request for Covid-19 vaccine again: Spokesperson – Deccan Herald
After reports of Pfizer withdrawing its application for emergency use authorisation of its Covid-19 vaccine in India, the company spokesperson said that it will resubmit…
Pfizer Inc said on Friday it had withdrawn an application for emergency-use authorisation of its Covid-19 vaccine in India, after failing to meet the drug regulator’s demand for a local safety and immunogenicity study.
The decision means the vaccine will not be available for sale in the world’s two most populous countries, India and China, in the near future. Both countries are running their immunisation campaigns using other products.
Unlike other companies conducting small studies in India for…
-
Noosa News20 hours agoTerrifying break-in at childcare centre on Sunshine Coast ends with death of man
-
General23 hours agoTrial of celebrity crocodile wrangler Matt Wright to hear from more witnesses
-
Noosa News21 hours agoWhy the Story Bridge won’t have a traffic lane repurposed for bikes and walkers
-
General24 hours agoPM kicks off roundtable with call for lasting reform